Company Overview of Palau Pharma S.A.
Palau Pharma S.A., a specialty pharmaceutical company, engages in the discovery and development of medicines for the treatment of inflammatory and autoimmune diseases. Its products address various diseases, such as asthma, allergic rhinitis, psoriasis, ulcerative colitis, rheumatoid arthritis, and atopic dermatitis, as well as organ transplant. Palau Pharma S.A. also provides ACTIVE, a drug-eluting coronary stent. The company was founded in 2006 and is based in Barcelona, Spain. Palau Pharma S.A. operates as a subsidiary of Grupo Uriach.
Pol. Ind. Riera de Caldes
Avinguda Camí Reial 51-57
Palau-solità i Plegamans
Founded in 2006
34 93 864 96 92
34 93 864 66 06
Key Executives for Palau Pharma S.A.
Similar Private Companies By Industry
|Ability Pharmaceuticals, S.L.||Europe|
|Activery Biotech SL||Europe|
|Aelix Therapeutics SL||Europe|
|AlbaJuna Therapeutics SL||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Palau Pharma S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.